1 |
pre-exposure prophylaxis
(4266 times)
|
Acquired Immunodeficiency Syndrome (1505 times)
|
MSM (845 times) HIV (354 times) ART (197 times)
|
2005 Tenofovir trials raise ethical issues.
|
2 |
Pre-exposure prophylaxis for HIV
(10 times)
|
Medicine (4 times)
|
MSM (3 times) AYA (1 time) CDC (1 time)
|
2014 Determinants of HIV testing among Nigerian couples: a multilevel modelling approach.
|
3 |
preexposure
(7 times)
|
Communicable Diseases (2 times)
|
PEP (4 times) RVNA (2 times) aORs (1 time)
|
2011 Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren.
|
4 |
pre-exposure prophylaxis for HIV prevention
(4 times)
|
Acquired Immunodeficiency Syndrome (3 times)
|
BMGF (1 time) CDC (1 time) DAIDS (1 time)
|
2010 Implications of HIV PrEP trials results.
|
5 |
plan recommends pre-exposure prophylaxis
(3 times)
|
Acquired Immunodeficiency Syndrome (1 time)
|
PEP (1 time)
|
2020 PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
|
6 |
Participants allocated in the intervention arm
(1 time)
|
Medicine (1 time)
|
AE (1 time)
|
2021 Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.
|
7 |
patients reported preexposure prophylaxis
(1 time)
|
Sexually Transmitted Diseases (1 time)
|
---
|
2022 Self-Reported Use of HIV Preexposure Prophylaxis Is Highly Accurate Among Sexual Health Clinic Patients in New York City.
|
8 |
population, daily oral chemoprophylaxis
(1 time)
|
Communicable Diseases (1 time)
|
---
|
2013 Strategies to manage the HIV epidemic in gay, bisexual, and other men who have sex with men.
|
9 |
Practices Regarding Pre-Exposure Prophylaxis
(1 time)
|
Environmental Health (1 time)
|
adjOR (1 time) AIDS (1 time) CI (1 time)
|
2021 Knowledge, Attitudes and Practices Regarding Pre-Exposure Prophylaxis (PrEP) in a Sample of Italian Men Who Have SEX with MEN (MSM).
|
10 |
Pre-exposure pharmacological prophylaxis
(1 time)
|
Legislation, Drug (1 time)
|
---
|
2017 Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.
|
11 |
pre-exposure prophylaxis medication
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
ACASI (1 time) ARVs (1 time) DBS (1 time)
|
2021 The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs.
|
12 |
Pre-exposure rabies prophylaxis
(1 time)
|
|
---
|
2021 Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure.
|
13 |
preexposicion
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
FSW (1 time)
|
2022 Cultivating PEARL (Promoting Empowerment and Risk Reduction): Formative Research for a PrEP Intervention Among Female Sex Workers in Baltimore, Maryland.
|
14 |
preexposure antiretroviral prophylaxis
(1 time)
|
Communicable Diseases (1 time)
|
HIV (1 time)
|
2022 Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children.
|
15 |
preexposure prophylaxis with antiretrovirals
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
---
|
2010 AIDS vaccines and preexposure prophylaxis: is synergy possible?
|
16 |
Prenatal epigenetic programming
(1 time)
|
Autistic Disorder (1 time)
|
EAAT3 (1 time) GI (1 time) PEP (1 time)
|
2012 Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism.
|
17 |
program is the first key population-led
(1 time)
|
Public Health (1 time)
|
aOR (1 time) MSM (1 time) TGW (1 time)
|
2019 Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
|
18 |
protective effect of preexposure prophylaxis
(1 time)
|
Medicine (1 time)
|
dATP (1 time) dCTP (1 time) dNTP (1 time)
|
2016 Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.
|